← Eichor
Study identifier: NCT06065124 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial

Condition: Heart Failure with Preserved Ejection Fraction · Atrial Fibrillation  ·  Sponsor: University Medical Center Groningen

PhaseNA
Planned participants108
Who can joinAll sexes, 45 Years to 70 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate if a bariatric surgery strategy will improve clinical endpoints, cardiac parameters and functional status in patients with obesity (with BMI 32-40 kg/m2) and symptomatic HF with preserved or mildly reduced LVEF in combination with AF, as compared to standard of care. Patients will be randomized to either the Intervention group receiving bariatric surgery including an intensive pre- and postoperative treatment scheme or to the control group receiving standard of care.

This description comes directly from the study's public registry record.

Talk to the study team

Michiel Rienstra, MD, PhD  ·  +31503611327  ·  m.rienstra@umcg.nl

Thomas M Gorter, MD, PhD  ·  tm.gorter@umcg.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Rijnstate HospitalArnhem, Gelderland, NetherlandsActive Not Recruiting
University Medical Center GroningenGroningen, Provincie Groningen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06065124